Sit Investment Associates’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-28,351
Closed -$767K 567
2024
Q2
$767K Hold
28,351
0.02% 379
2024
Q1
$519K Hold
28,351
0.01% 405
2023
Q4
$348K Hold
28,351
0.01% 429
2023
Q3
$425K Hold
28,351
0.01% 411
2023
Q2
$921K Hold
28,351
0.02% 368
2023
Q1
$1.11M Hold
28,351
0.03% 350
2022
Q4
$1.5M Hold
28,351
0.04% 320
2022
Q3
$1.28M Hold
28,351
0.04% 321
2022
Q2
$1.03M Hold
28,351
0.03% 332
2022
Q1
$1.17M Hold
28,351
0.03% 337
2021
Q4
$1.21M Hold
28,351
0.03% 350
2021
Q3
$1.56M Hold
28,351
0.04% 321
2021
Q2
$1.36M Hold
28,351
0.03% 338
2021
Q1
$1.44M Hold
28,351
0.04% 330
2020
Q4
$1.79M Buy
+28,351
New +$1.76M 0.05% 308

Other funds holding SILK

Sit Investment Associates's SILK Position: Q3 2024 in Review

Sit Investment Associates sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 28,351 shares — an estimated $767K sold.

Sit Investment Associates first reported a position in SILK in Q4 2020 and held it in 15 quarters. The position peaked at $1.79M in Q4 2020. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Sit Investment Associates reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Sit Investment Associates sold 28,351 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $767K.
  • Sit Investment Associates first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2020 and held it in 15 quarters.
  • Sit Investment Associates's Silk Road Medical, Inc. Common Stock position peaked at $1.79M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Sit Investment Associates's 13F filing for Q3 2024, filed 13 Nov 2024.